Teva Asks High Court to Block Generics Ahead of Copaxone Ruling

could usher in a new era of deference to trial judges in patent cases. But Teva's lawyers reminded the Supreme Court on Monday that there's real money at stake in the case as well.

Sign up for a free trial now!'s Elite 15-day trial gives you:

  • All access pass to legal news across ALM's Network
  • News by Practice Area, available exclusively on
  • The free InPractice digital newsletter
  • Personalized legal news on the mobile App

During and after your trial, you'll receive the benefits of an ALM digital membership, including a subscription to the Newswire digital newsletter.